Target Price | $81.60 |
Price | $64.70 |
Potential | 26.12% |
Number of Estimates | 27 |
27 Analysts have issued a price target Microchip Technology 2026 . The average Microchip Technology target price is $81.60. This is 26.12% higher than the current stock price. The highest price target is $94.50 46.06% , the lowest is $60.60 6.34% . | |
A rating was issued by 32 analysts: 24 Analysts recommend Microchip Technology to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Microchip Technology stock has an average upside potential 2026 of 26.12% . Most analysts recommend the Microchip Technology stock at Purchase. |
28 Analysts have issued a sales forecast Microchip Technology 2026 . The average Microchip Technology sales estimate is $4.7b . This is 11.64% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $5.2b 22.10% , the lowest is $4.4b 4.58% .
This results in the following potential growth metrics:
2025 | $4.4b | 42.35% |
---|---|---|
2026 | $4.7b | 7.44% |
2027 | $5.7b | 20.87% |
2028 | $6.7b | 17.83% |
2029 | $6.7b | 0.55% |
2030 | $7.2b | 8.00% |
14 Analysts have issued an Microchip Technology EBITDA forecast 2026. The average Microchip Technology EBITDA estimate is $1.7b . This is 146.05% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.1b 201.64% , the lowest is $1.2b 82.27% .
This results in the following potential growth metrics and future EBITDA Margins:
2025 | $866m | 72.62% |
---|---|---|
2026 | $1.7b | 94.14% |
2027 | $2.4b | 42.93% |
2028 | $2.6b | 7.86% |
2029 | $2.9b | 12.30% |
2030 | $3.3b | 14.59% |
2025 | 19.68% | 52.51% |
---|---|---|
2026 | 35.57% | 80.71% |
2027 | 42.06% | 18.25% |
2028 | 38.50% | 8.46% |
2029 | 43.48% | 12.94% |
2030 | 46.13% | 6.09% |
29 Microchip Technology Analysts have issued a net profit forecast 2026. The average Microchip Technology net profit estimate is $818m . This is 553.14% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $958m 630.27% , the lowest is $677m 474.84% .
This results in the following potential growth metrics and future Net Margins:
2025 | $-2.7m | 100.14% |
---|---|---|
2026 | $818m | 30,410.00% |
2027 | $1.4b | 76.31% |
2028 | $1.8b | 27.63% |
2029 | $2.2b | 17.77% |
2030 | $2.6b | 18.78% |
2025 | -0.06% | 100.25% |
---|---|---|
2026 | 17.31% | 28,319.15% |
2027 | 25.24% | 45.81% |
2028 | 27.34% | 8.32% |
2029 | 32.38% | 18.43% |
2030 | 35.61% | 9.98% |
29 Analysts have issued a Microchip Technology forecast for earnings per share. The average Microchip Technology EPS is $1.52 . This is 547.06% higher than earnings per share in the financial year 2025. The highest EPS forecast is $1.77 620.59% , the lowest is $1.25 467.65% .
This results in the following potential growth metrics and future valuations:
2025 | $-0.01 | 100.29% |
---|---|---|
2026 | $1.52 | 15,300.00% |
2027 | $2.67 | 75.66% |
2028 | $3.41 | 27.72% |
2029 | $4.02 | 17.89% |
2030 | $4.77 | 18.66% |
Current | -190.29 | 747.24% |
---|---|---|
2026 | 42.67 | 122.42% |
2027 | 24.20 | 43.29% |
2028 | 18.96 | 21.65% |
2029 | 16.10 | 15.08% |
2030 | 13.55 | 15.84% |
Based on analysts' sales estimates for 2026, the Microchip Technology stock is valued at an EV/Sales of 8.42 and an P/S ratio of 7.38 .
This results in the following potential growth metrics and future valuations:
Current | 9.40 | 35.84% |
---|---|---|
2026 | 8.42 | 10.45% |
2027 | 6.96 | 17.27% |
2028 | 5.91 | 15.13% |
2029 | 5.94 | 0.55% |
2030 | 5.50 | 7.41% |
Current | 8.24 | 36.60% |
---|---|---|
2026 | 7.38 | 10.43% |
2027 | 6.11 | 17.27% |
2028 | 5.18 | 15.13% |
2029 | 5.21 | 0.55% |
2030 | 4.83 | 7.41% |
Microchip Technology...
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Aug 08 2025 |
Raymond James |
Strong Buy
➜
Strong Buy
|
Unchanged | Aug 08 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Aug 08 2025 |
Susquehanna |
Positive
➜
Positive
|
Unchanged | Jul 22 2025 |
Stifel |
Buy
➜
Buy
|
Unchanged | Jul 18 2025 |
Goldman Sachs |
➜
Buy
|
Initiated | Jul 10 2025 |
Mizuho |
Outperform
➜
Outperform
|
Unchanged | Jul 08 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Aug 08 2025 |
Unchanged
Raymond James:
Strong Buy
➜
Strong Buy
|
Aug 08 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Aug 08 2025 |
Unchanged
Susquehanna:
Positive
➜
Positive
|
Jul 22 2025 |
Unchanged
Stifel:
Buy
➜
Buy
|
Jul 18 2025 |
Initiated
Goldman Sachs:
➜
Buy
|
Jul 10 2025 |
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Jul 08 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.